Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Ruixing, Yin ^a   Yiyang, Li ^a   Meng, Li ^a   Kela, Li ^a   Xingjiang, Long ^a   Lin, Zhang ^a   Wanying, Liu ^a   Jinzhen, Wu ^a   Dezhai, Yang ^b   Weixiong, Lin ^b  

^a First Affiliated Hospital   (China)

^b Medical Scientific Research Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; APOA1 PROTEIN, HUMAN; LIPID;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE SEQUENCE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; MALE; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; BLOOD; CHEMISTRY; CHINA; DRINKING BEHAVIOR; GENETIC ASSOCIATION; GENETICS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; CHINA; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPIDS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STATISTICS AS TOPIC; TRIGLYCERIDES; YOUNG ADULT;

EID: 77955540310     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-86     Document Type: Article

References (75)

1. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. MA Austin, Am J Epidemiol 1989 129 249 59 2643302
2. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. JE Hokanson MA Austin, J Cardiovasc Risk 1996 3 213 9 10.1097/00043798-199604000-00014 8836866
3. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. PJ Talmud E Hawe GJ Miller SE Humphries, Arterioscler Thromb Vasc Biol 2002 22 1918 23 10.1161/01.ATV.0000035521.22199.C7 12426225
4. Serum lipid survey and its recent trend in the general Japanese population in 2000. H Arai A Yamamoto Y Matsuzawa Y Saito N Yamada S Oikawa H Mabuchi T Teramoto J Sasaki N Nakaya H Itakura Y Ishikawa Y Ouchi H Horibe, J Atheroscler Thromb 2005 12 98 106 15942120
5. Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men: Results from a 10-year cohort study. H Satoh T Nishino K Tomita H Tsutsui, Circ J 2006 70 227 31 10.1253/circj.70.227 16501284
6. Review of risk factors for cardiovascular diseases. LL Wu, Ann Clin Lab Sci 1999 29 127 33 10219700
7. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. M You DW Crabb, Am J Physiol Gastrointest Liver Physiol 2004 287 1 G6 10.1152/ajpgi.00056.2004 15194557
8. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. WP Castelli JT Doyle T Gordon CG Hames MC Hjortland SB Hulley A Kagan WJ Zukel, Lancet 1977 2 153 5 10.1016/S0140-6736(77)90176-3 69778
9. Diet, alcohol consumption, and serum lipid levels of the middle-aged and elderly in the Guangxi Bai Ku Yao and Han populations. Y Ruixing P Shangling C Hong Y Hanjun W Hai C Yuming W Jinzhen H Feng L Meng L Muyan, Alcohol 2008 42 219 29 10.1016/j.alcohol.2008.01.009 18420116
10. A prospective study of trigliceryde level, low-density lipoprotein particle diameter, and risk of myocardial infarction. MJ Stampfer RM Krauss J Ma PJ Blanche LG Holl FM Sacks CH Hennekens, JAMA 1996 276 882 8 10.1001/jama.276.11.882 8782637
11. Modulation of lipoprotein lipase activity by apolipoproteins. C Wang WJ McConathy HU Kloer P Alaupovic, J Clin Invest 1985 75 384 90 10.1172/JCI111711 3973011
12. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins. NA Le JC Gibson HN Ginsberg, J Lipid Res 1988 29 669 77 3411241
13. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Y Ito N Azrolan A O'Connell A Walsh JL Breslow, Science 1990 249 790 3 10.1126/science.2167514 2167514
14. Human apolipoprotein AI-CIII gene complex is located on chromosome 11. GA Bruns SK Karanthasis JL Breslow, Arteriosclerosis 1984 4 97 102 6422919
15. Apolipoprotein C-III gene variation and dyslipidaemia. PJ Talmud SE Humphries, Curr Opin Lipidol 1997 8 154 8 10.1097/00041433-199706000-00005 9211063
16. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. RA Hegele PW Connelly AJ Hanley F Sun SB Harris B Zinman, Arterioscler Thromb Vasc Biol 1997 17 2753 8 9409252
17. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. JM Ordovas F Civeira J Genest Jr S Craig AH Robbins T Meade M Pocovi PM Frossard U Masharani PW Wilson, Atherosclerosis 1991 87 75 86 10.1016/0021-9150(91)90234-T 1678604
18. Haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia. A study in a Japanese population. A Rees J Stocks H Paul Y Ohuchi D Galton, Hum Genet 1986 72 168 71 10.1007/BF00283939 3080367
19. Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. SH Hong WH Park CC Lee JH Song JQ Kim, Clin Chem 1997 43 13 7 8990215
20. Genetic studies of human apolipoproteins. XIII. Quantitative polymorphism of apolipoprotein C-III in the Mayans of the Yucatan Peninsula. RE Ferrell MI Kamboh PP Majumder R Valdez KM Weiss, Hum Hered 1990 40 127 35 10.1159/000153919 2365371
21. Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France. J Dallongeville A Meirhaeghe D Cottel JC Fruchart P Amouyel N Helbecque, Atherosclerosis 2000 150 149 57 10.1016/S0021-9150(99)00362-7 10781646
22. DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index. JH Wu JT Kao MS Wen SK Lo, J Formos Med Assoc 2000 99 367 74 10870325
23. Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men. DM Waterworth PJ Talmud SR Bujac RM Fisher GJ Miller SE Humphries, Arterioscler Thromb Vasc Biol 2000 20 2663 9 11116069
24. Variable effects of the APOC3-482C > T variant on insulin, glucose and triglyceride concentrations in different ethnic groups. DM Waterworth PJ Talmud SE Humphries PD Wicks GA Sagnella P Strazzullo KG Alberti DG Cook FP Cappuccio, Diabetologia 2001 44 245 8 10.1007/s001250051607 11270684
25. Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia. M Buzza Y Fripp RJ Mitchell, Ann Hum Biol 2001 28 481 90 10.1080/03014460010019777 11572515
26. Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus. D Corella M Guillén C Siz O Portolés A Sabater J Folch JM Ordovas, J Lipid Res 2002 43 416 27 11893778
27. Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians. S Chhabra R Narang LR Krishnan S Vasisht DP Agarwal LM Srivastava SC Manchanda N Das, BMC Genet 2002 3 9 10.1186/1471-2156-3-9 12052247
28. Apolipoprotein C-III and E polymorphisms and cardiovascular syndrome, hyperlipidemia, and insulin resistance in renal transplantation. E Rodrigo D Gonzlez-Lamũo JC Ruiz G Fernndez-Fresnedo D Isla J Gonzlez-Cotorruelo JA Zubimendi AL De Francisco M García-Fuentes M Arias, Am J Transplant 2002 2 343 8 10.1034/j.1600-6143.2002.20409.x 12118856
29. Influence of the APOC3 -2854T>G polymorphism on plasma lipid levels: effect of age and gender. AM Minihane YE Finnegan P Talmud EC Leigh-Firbank CM Williams, Biochim Biophys Acta 2002 1583 311 4 12176399
30. Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study. SE Humphries L Berglund CR Isasi JD Otvos D Kaluski RJ Deckelbaum S Shea PJ Talmud, Nutr Metab Cardiovasc Dis 2002 12 163 72 12514935
31. Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men. C Couillard MC Vohl JC Engert I Lemieux A Houde N Almeras D Prud'homme A Nadeau JP Despres J Bergeron, J Lipid Res 2003 44 986 93 10.1194/jlr.M300043-JLR200 12588953
32. Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism. A Espino-Montoro M Barrios-Artillo JM Lápez-Chozas A Cayuela P Stiefel J Villar, Nutr Metab Cardiovasc Dis 2003 13 194 201 10.1016/S0939-4753(03)80011-X 14650351
33. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. AP Surguchov GP Page L Smith W Patsch E Boerwinkle, Arterioscler Thromb Vasc Biol 1996 16 941 7 8696957
34. Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population. GP Li JY Wang SK Yan BS Chen H Xue G Wu, Clin Genet 2004 65 470 6 10.1111/j.1399-0004.2004.00251.x 15151505
35. Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians. C Garenc S Aubert J Laroche J Girouard MC Vohl J Bergeron F Rousseau P Julien, J Hum Genet 2004 49 691 700 10.1007/s10038-004-0208-6 15549499
36. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. JM Guettier A Georgopoulos MY Tsai V Radha S Shanthirani R Deepa M Gross G Rao V Mohan, J Clin Endocrinol Metab 2005 90 1705 11 10.1210/jc.2004-1338 15598690
37. Effect of the APOC3 Sst I SNP on fasting triglyceride levels in men heterozygous for the LPL P207L deficiency. C Garenc C Couillard N Laflamme F Cadelis C Gagné P Couture P Julien J Bergeron, Eur J Hum Genet 2005 13 1159 65 10.1038/sj.ejhg.5201469 16015281
38. APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica. EA Ruiz-Narvez Y Yang Y Nakanishi J Kirchdorfer H Campos, J Lipid Res 2005 46 2605 13 10.1194/jlr.M500040-JLR200 16192625
39. Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake. KL Herron IE Lofgren X Adiconis JM Ordovas ML Fernandez, Atherosclerosis 2006 184 113 20 10.1016/j.atherosclerosis.2005.03.023 16326171
40. Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines. MC Huang TN Wang YL Liu TH Pa HP Tu YC Huang WT Chang YC Ko, Circ J 2006 70 1030 6 10.1253/circj.70.1030 16864937
41. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. DM Hallman SR Srinivasan W Chen E Boerwinkle GS Berenson, Metabolism 2006 55 1574 81 10.1016/j.metabol.2006.07.018 17142127
42. The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes. B Dorfmeister JA Cooper JW Stephens H Ireland SJ Hurel SE Humphries PJ Talmud, Biochim Biophys Acta 2007 1772 355 63 17197160
43. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes. M Fiegenbaum FM de Andrade MH Hutz, Clin Chim Acta 2007 380 175 81 10.1016/j.cca.2007.02.007 17367769
44. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome. M Miller J Rhyne H Chen V Beach R Ericson K Luthra M Dwivedi A Misra, Arch Med Res 2007 38 444 51 10.1016/j.arcmed.2006.10.013 17416293
45. Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample. RL Pollex MR Ban TK Young P Bjerregaard SS Anand S Yusuf B Zinman SB Harris AJ Hanley PW Connelly MW Huff RA Hegele, BMC Med Genet 2007 8 80 10.1186/1471-2350-8-80 18096054
46. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. KL Chien WH Fang HC Wen HP Lin YL Lin SW Lin JH Wu JT Kao, Clin Chim Acta 2008 390 56 62 10.1016/j.cca.2007.12.014 18206649
47. Association of APOC3 polymorphisms with both dyslipidemia and lipoatrophy in HAART-receiving patients. E Bonnet J Bernard J Fauvel P Massip JB Ruidavets B Perret, AIDS Res Hum Retroviruses 2008 24 169 71 10.1089/aid.2007.0076 18240956
48. Common variants APOC3, APOA5, APOE and PON1 are associated with variation in plasma lipoprotein traits in Greenlanders. P Lahiry MR Ban RL Pollex RD Feldman CG Sawyez MW Huff TK Young P Bjerregaard RA Hegele, Int J Circumpolar Health 2007 66 390 400 18274205
49. Apolipoprotein CIII polymorphism and triglyceride levels of a Japanese population living in Southern Brazil. L Parzianello G Oliveira JC Coelho, Braz J Med Biol Res 2008 41 462 7 10.1590/S0100-879X2008005000022 18560672
50. Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction. A Kawakami M Osaka M Tani H Azuma FM Sacks K Shimokado M Yoshida, Circulation 2008 118 731 42 10.1161/CIRCULATIONAHA.108.784785 18663085
51. Birth weight and blood lipid levels in Spanish adolescents: influence of selected APOE, APOC3 and PPARgamma2 gene polymorphisms. The AVENA Study. JR Ruiz I Labayen FB Ortega LA Moreno D Gonzlez-Lamũo A Martí E Nova MG Fuentes C Redondo-Figuero JA Martínez M Sjöström MJ Castillo AVENA Study Group, BMC Med Genet 2008 9 98 10.1186/1471-2350-9-98 19000312
52. Apolipoprotein C-III gene polymorphism and several environmental factors with serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations. L Yiyang Y Ruixing L Meng L Kela L Xingjiang Z Lin L Wanying P Shangling Y Dezhai L Weixiong, J Investig Med 2010 58 777 85 20517165
53. APOC3 mutation, serum triglyceride concentrations, and coronary heart disease. MY Tsai JM Ordovas, Clin Chem 2009 55 1274 6 10.1373/clinchem.2009. 124669 19443564
54. Common genetic variants of lipoprotein lipase and apolipoproteins AI-CIII that relate to coronary artery disease: a study in Chinese and European subjects. Q Zhang Y Liu BW Liu P Fan J Cavanna DJ Galton, Mol Genet Metab 1998 64 177 83 10.1006/mgme.1998.2712 9719626
55. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. GT Russo JB Meigs LA Cupples S Demissie JD Otvos PW Wilson C Lahoz D Cucinotta P Couture T Mallory EJ Schaefer JM Ordovas, Atherosclerosis 2001 158 173 81 10.1016/S0021-9150(01)00409-9 11500189
56. ApoC-III gene polymorphisms and risk of coronary artery disease. O Olivieri C Stranieri A Bassi B Zaia D Girelli F Pizzolo E Trabetti S Cheng MA Grow PF Pignatti R Corrocher, J Lipid Res 2002 43 1450 7 10.1194/jlr.M200145- JLR200 12235176
57. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. MG Baroni A Berni S Romeo M Arca T Tesorio G Sorropago U Di Mario DJ Galton, BMC Med Genet 2003 4 8 10.1186/1471-2350-4-8 12964943
58. Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD. S Chhabra R Narang R Lakshmy S Vasisht DP Agarwal LM Srivastava SC Manchanda N Das, Mol Cell Biochem 2004 259 59 66 10.1023/B:MCBI.0000021345.31556.c9 15124908
59. Contrasting multi-site genotypic distributions among discordant quantitative phenotypes: the APOA1/C3/A4/A5 gene cluster and cardiovascular disease risk factors. BA Payseur AG Clark J Hixson E Boerwinkle CF Sing, Genet Epidemiol 2006 30 508 18 10.1002/gepi.20163 16800005
60. Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with coronary artery disease. A Muendlein CH Saely T Marte F Schmid L Koch P Rein P Langer S Aczel H Drexel, Atherosclerosis 2008 199 179 86 10.1016/j.atherosclerosis.2007.10.030 18289550
61. Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction. EA Ruiz-Narvez FM Sacks H Campos, Am J Clin Nutr 2008 87 1932 8 18541587
62. Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. J Shanker G Perumal VS Rao NB Khadrinarasimhiah S John S Hebbagodi M Mukherjee VV Kakkar, Lipids Health Dis 2008 7 33 10.1186/1476-511X-7-33 18801202
63. Effects of demographic, dietary and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. Y Ruixing C Yuming P Shangling H Fengping L Tangwei Y Dezhai W Jinzhen Y Limei L Weixiong L Rongshan H Jiandong, Eur J Cardiovasc Prev Rehabil 2006 13 977 84 10.1097/01.hjr.0000239476.79428.25 17143131
64. Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Y Ruixing Y Limei C Yuming Y Dezhai L Weixiong L Muyan H Fengping W Jinzhen Y Guangqing N Zhenbiao, Hypertens Res 2006 29 423 32 10.1291/hypres.29.423 16940705
65. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. E De Oliveira ER Silva D Foster M McGee Harper CE Seidman JD Smith JL Breslow EA Brinton, Circulation 2000 102 2347 52 11067787
66. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. DP Agarwal, Alcohol Alcohol 2002 37 409 15 12217928
67. Moderate alcohol intake and lower coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. EB Rimm P Williams K Fosher M Criqui MJ Stampfer, BMJ 1999 319 1523 8 10591709
68. Effects of alcohol lipoproteins in relation to coronary heart disease. MJ Savolainen YA Kesaniemi, Curr Opin Lipidol 1995 6 243 50 10.1097/00041433- 199508000-00009 7670754
69. Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. YL Ko YS Ko SM Wu MS Teng FR Chen TS Hsu CW Chiang YS Lee, Hum Genet 1997 100 327 33 10.1007/s004390050511 9272150
70. Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population. H Bai K Saku R Liu M Imamura K Arakawa, Hum Genet 1995 95 102 4 10.1007/BF00225084 7814010
71. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects. M Marcil B Boucher E Gagné J Davignon M Hayden J Genest Jr, J Lipid Res 1996 37 309 19 9026529
72. Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study. F Kee P Amouyel F Fumeron D Arveiler JP Cambou A Evans F Cambien JC Fruchart P Ducimetière J Dallongeville, Atherosclerosis 1999 145 187 95 10.1016/S0021-9150(99)00066-0 10428310
73. Plasma triglyceride and HDL-cholesterol concentrations in Vietnamese girls are affected by lipoprotein lipase, but not apolipoprotein CIII polymorphism. NN Thu TT Mai R Ohmori M Kuroki NV Chuyen NT Hung M Kawakami K Kondo, J Nutr 2006 136 1488 92 16702309
74. Types of alcoholic beverages and blood lipids in a French population. JB Ruidavets P Ducimetière D Arveiler P Amouyel A Bingham A Wagner D Cottel B Perret J Ferrières, J Epidemiol Community Health 2002 56 24 8 10.1136/jech.56.1.24 11801616
75. Alcohol intake and serum lipids in a Japanese population. SR Choudhury H Ueshima Y Kita KM Kobayashi A Okayama M Yamakawa Y Hirao M Ishikawa Y Miyoshi, Int J Epidemiol 1994 23 940 7 10.1093/ije/23.5.940 7860174